The content is available as a PDF (215.4 KB).
References
- 1.Poskanzer D.C, Schwab R.S. Cohort analysis of Parkinson's syndrome: evidence for a single etiology related to sub-clinical infection about 1920. J. Chron. Dis. 1963;16:961–973. doi: 10.1016/0021-9681(63)90098-5. [DOI] [PubMed] [Google Scholar]
- 2.Sasco A.J, Paffenberger R.S., Jr. Measles infection and Parkinson's disease. Am. J. Epidemiol. 1985;122:1017–1031. doi: 10.1093/oxfordjournals.aje.a114183. [DOI] [PubMed] [Google Scholar]
- 3.Goto A. A follow-up study of Japanese B encephalitis. Psychiat. Neurol. Jpn. 1962;64:236–266. [PubMed] [Google Scholar]
- 4.Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J. Neurology. 1993;240:59–60. doi: 10.1007/BF00838449. [DOI] [PubMed] [Google Scholar]
- 5.Mulder D.W, Parrott M, Thaler M. Sequelae of Western equine encephalitis. Neurology. 1951;1:318–327. doi: 10.1212/wnl.1.7-8.318. [DOI] [PubMed] [Google Scholar]
- 6.Shoji H, Murakami T, Murai I. A follow-up study by CT and MRI in 3 cases of Japanese encephalitis. Neuroradiology. 1990;32:215–219. doi: 10.1007/BF00589115. [DOI] [PubMed] [Google Scholar]
- 7.Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H. The substantia nigra is a major target for neurovirulent influenza A virus. J. Exp. Med. (in press). [DOI] [PMC free article] [PubMed]
- 8.Eadie M.J, Sutherland J.M, Doherty R.L. Encephalitis in etiology of parkinsonism in Australia. Arch. Neurology. 1965;12:240–245. doi: 10.1001/archneur.1965.00460270016002. [DOI] [PubMed] [Google Scholar]
- 9.Elizan T.S, Madden D.L, Noble G.R. Viral antibodies in serum and CSF of Parkinsonian patients and controls. Arch. Neurology. 1979;36:529–534. doi: 10.1001/archneur.1979.00500450023002. [DOI] [PubMed] [Google Scholar]
- 10.Treves T.A, Wechsler M, Rabey J.M, Korczyn A.D. Risk factors for Parkinson's disease: case-control study with temporal approach. Neurology. 1991;41(suppl 1):371. [Google Scholar]
- 11.Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov. Disord. 1992;7:153–158. doi: 10.1002/mds.870070210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yamada T, Horisberger M.A, Kawaguchi N, Moroo I, Toyoda T. Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci. Lett. 1995;181:61–64. doi: 10.1016/0304-3940(94)90560-6. [DOI] [PubMed] [Google Scholar]
- 13.Kohbata S, Beaman B.L. L-Dopa-responsive movement disorder caused by Nocardia asteroids localized in the brains of mice. Infect Immunology. 1991;59:181–191. doi: 10.1128/iai.59.1.181-191.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kohbata S, Shimokawa K. Circulating antibody to Nocardia in the serum of patients with Parkinson's disease. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, editors. Parkinson's Disease: From Basic Research to Treatment. 60th Edn. Raven Press; New York: 1993. pp. 355–357. [PubMed] [Google Scholar]